Phase II study of oral ridaforolimus in women with recurrent or metastatic endometrial cancer-Reference-Cited by-同舟云学术

Phase II study of oral ridaforolimus in women with recurrent or metastatic endometrial cancer

Published:2014-11 Issue:2 Volume:135 Page:184-189
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Tsoref Daliah,Welch Stephen,Lau Susie,Biagi James,Tonkin Katia,Martin Lee Ann,Ellard Susan,Ghatage Prafull,Elit Laurie,Mackay Helen J.,Allo Ghassan,Tsao Ming-Sound,Kamel-Reid Suzanne,Eisenhauer Elizabeth A.,Oza Amit M.

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Oncology

Reference21 articles.

1. Handbook of gynaecologic oncology;Sabbatini,2001

2. Phase III trial of doxorubicin with or without cisplatin in advanced endometrial carcinoma: a Gynecologic Oncology Group Study;Thigpen;J Clin Oncol,2004

3. Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: definitive results of a randomized study (55872) by the EORTC Gynecological Cancer Group;Aapro;Ann Oncol,2003

4. Chemotherapy in endometrial cancer;Obel;Clin Adv Hematol Oncol,2006

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Locally advanced and metastatic endometrial cancer: Current and emerging therapies;Cancer Treatment Reviews;2024-09

2. The Cytoprotective and Cytotoxic Functions of Autophagy in Response to mTOR Inhibitors;Frontiers in Bioscience-Landmark;2024-06-24

3. Comparative effects of progestin-based combination therapy for endometrial cancer or atypical endometrial hyperplasia: a systematic review and network meta-analysis;Frontiers in Oncology;2024-05-03

4. Molecular characterization as new driver in prognostic signatures and therapeutic strategies for endometrial cancer;Cancer Treatment Reviews;2024-05

5. High-Grade Endometrial Cancer: Molecular Subtypes, Current Challenges, and Treatment Options;Reproductive Sciences;2024-04-24